Natera, Inc. NTRA Product revenues — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Natera, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Natera, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Natera, Inc.'s product revenues — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Natera, Inc.'s product revenues — total revenues?
- Natera, Inc. (NTRA) reported product revenues — total revenues of $693.87M in Q1 2026.
- How has Natera, Inc.'s product revenues — total revenues changed year-over-year?
- Natera, Inc.'s product revenues — total revenues increased by 38.8% year-over-year, from $500.04M to $693.87M.
- What is the long-term trend for Natera, Inc.'s product revenues — total revenues?
- Over 4 years (2021 to 2025), Natera, Inc.'s product revenues — total revenues has grown at a 41.0% compound annual growth rate (CAGR), from $580.08M to $2.3B.
- What does product revenues — total revenues mean?
- This metric represents the total gross revenue generated specifically from the sale of diagnostic testing products and associated molecular technology services. It reflects the core commercial performance of the company's proprietary testing portfolio, excluding non-product related income such as licensing or research collaborations. This figure is a primary indicator of market adoption and the scale of the company's diagnostic testing business.